Aliases & Classifications for Arteriosclerosis Obliterans

About this section

Arteriosclerosis Obliterans, Aliases & Descriptions:

Name: Arteriosclerosis Obliterans 9 11 43 60


External Ids:

Disease Ontology9 DOID:5160
SNOMED-CT55 60625000, 361133006
MeSH33 D001162

Summaries for Arteriosclerosis Obliterans

About this section


Wikipedia:63 Arteriosclerosis obliterans is an occlusive arterial disease most prominently affecting the abdominal... more...

MalaCards based summary: Arteriosclerosis Obliterans is related to arteriosclerosis and peripheral vascular disease. An important gene associated with Arteriosclerosis Obliterans is SELP (selectin P (granule membrane protein 140kDa, antigen CD62)), and among its related pathways are Spinal Cord Injury and amb2 Integrin signaling. The drugs tolazoline and tolazoline hydrochloride and the compounds thiolutin and heparin sodium salt have been mentioned in the context of this disorder. Affiliated tissues include heart, bone marrow and bone, and related mouse phenotypes are immune system and cellular.

Related Diseases for Arteriosclerosis Obliterans

About this section

Diseases related to Arteriosclerosis Obliterans via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 90)
idRelated DiseaseScoreTop Affiliating Genes
1arteriosclerosis31.4VCAM1, ADIPOQ, ICAM1, HGF
2peripheral vascular disease30.6SELP, VCAM1
3ischemia30.4SELP, ICAM1, HGF
4coronary artery disease30.2ADIPOQ, VCAM1, SELP
5atherosclerosis30.1SELP, VCAM1, ADIPOQ, ICAM1
6vascular disease29.9SELP, VCAM1, ADIPOQ, ICAM1
7thromboangiitis obliterans10.6
8aneurysm10.5
9common cold10.4ICAM1
10malaria10.4ICAM1
11aortic aneurysm10.4
12liver disease10.3ICAM1
13myocardial infarction10.3
14intermittent claudication10.3
15ischemic heart disease10.3
16artery disease10.3
17antiphospholipid syndrome10.2VCAM1, SELP
18henoch-schoenlein purpura10.2ICAM1, VCAM1
19sickle cell disease10.2SELP, VCAM1
20inclusion body myositis10.2VCAM1, ICAM1
21hyperhomocysteinemia10.2VCAM1, SELP
22rheumatoid vasculitis10.2ICAM1, VCAM1
23leukostasis10.2ICAM1, VCAM1
24oral lichen planus10.2ICAM1, VCAM1
25vernal keratoconjunctivitis10.2VCAM1, ICAM1
26monocytic leukemia10.2SELP, VCAM1
27coronary stenosis10.2ADIPOQ, SELP
28rhinitis10.2ICAM1, VCAM1
29lupus nephritis10.2VCAM1, ICAM1
30systemic lupus erythematosus10.2
31wrinkles10.2
32chronic venous insufficiency10.2
33peripheral artery disease10.2
34abdominal aortic aneurysm10.2
35cerebritis10.2
36lupus erythematosus10.2
37purpura10.2
38thrombophlebitis10.2
39venous insufficiency10.2
40light chain deposition disease10.2
41cerebral arteriosclerosis10.2
42blindness10.2
43endotheliitis10.2
44dermatomyositis10.2VCAM1, ICAM1
45polymyositis10.2ICAM1, VCAM1
46myositis10.2VCAM1, ICAM1
47synovitis10.2ICAM1, VCAM1
48microvascular complications of diabetes 510.2ICAM1, VCAM1
49connective tissue disease10.2VCAM1, ICAM1
50stroke, ischemic10.2ICAM1, VCAM1

Graphical network of the top 20 diseases related to Arteriosclerosis Obliterans:



Diseases related to arteriosclerosis obliterans

Symptoms for Arteriosclerosis Obliterans

About this section

Drugs & Therapeutics for Arteriosclerosis Obliterans

About this section

Drug clinical trials:

Search ClinicalTrials for Arteriosclerosis Obliterans

Search NIH Clinical Center for Arteriosclerosis Obliterans

Inferred drug relations via UMLS60/NDF-RT39:

Genetic Tests for Arteriosclerosis Obliterans

About this section

Anatomical Context for Arteriosclerosis Obliterans

About this section

MalaCards organs/tissues related to Arteriosclerosis Obliterans:

31
Heart, Bone marrow, Bone, Skin, Spleen, T cells, Endothelial

Animal Models for Arteriosclerosis Obliterans or affiliated genes

About this section

MGI Mouse Phenotypes related to Arteriosclerosis Obliterans:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053878.1SELP, VCAM1, ADIPOQ, ICAM1
2MP:00053848.1HGF, ICAM1, ADIPOQ, SELP
3MP:00053857.6HGF, ICAM1, ADIPOQ, VCAM1, SELP
4MP:00053977.6SELP, VCAM1, ADIPOQ, ICAM1, HGF
5MP:00053787.5SELP, VCAM1, ADIPOQ, ICAM1, HGF
6MP:00107687.4HGF, ICAM1, ADIPOQ, VCAM1, SELP

Publications for Arteriosclerosis Obliterans

About this section

Articles related to Arteriosclerosis Obliterans:

(show top 50)    (show all 228)
idTitleAuthorsYear
1
MiR-142-3p attenuates the migration of CD4a8_ T cells through regulating actin cytoskeleton via RAC1 and ROCK2 in arteriosclerosis obliterans. (24743945)
2014
2
Involvement of MicroRNA-133a in the Development of Arteriosclerosis Obliterans of the Lower Extremities via RhoA Targeting. (25445891)
2014
3
Long-term effects of beraprost sodium on arteriosclerosis obliterans: a single-center retrospective study of Japanese patients. (23749750)
2013
4
Retrograde perfusion of the hind leg in diabetic patients suffering from arteriosclerosis obliterans: theoretical considerations of oxygen supply and lymphatic flow based on rat models. (22259111)
2012
5
A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol. (23097651)
2012
6
Study design of SEASON registry: prospective Surveillance of cardiovascular Events in an Antiplatelet-treated arterioSclerosis Obliterans patients in JapaN )SEASON). (20966606)
2010
7
Long-term follow-up of Symphony nitinol stents in iliac arteriosclerosis obliterans. (18270875)
2008
8
Serum adiponectin and markers of endothelial injury in hemodialysis patients with arteriosclerosis obliterans. (18175063)
2008
9
Cost-effectiveness of Liple (LipoPGE1) for arteriosclerosis obliterans patients in Japan: an economic evaluation using the EQ-5D instrument. (16763534)
2006
10
Low-density lipoprotein apheresis in a patient with arteriosclerosis obliterans and light chain deposition disease. (15224807)
2004
11
Three cases of ischemic ulcer due to arteriosclerosis obliterans responding to basic fibroblast growth factor spray. (15372302)
2004
12
Effect of the serotonin blocker sarpogrelate on circulating interleukin-18 levels in patients with diabetes and arteriosclerosis obliterans. (15080020)
2004
13
Estimating the stenosis probabilities in arteriosclerosis obliterans using generalized estimating equations. (12820280)
2003
14
A case of arteriosclerosis obliterans with monitored regional oxygen saturation during treatment with a lumbar sympathetic ganglion block. (14556145)
2003
15
Usefulness of the Symphony Nitinol Stent for arteriosclerosis obliterans. (12419929)
2002
16
The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans. (9698948)
1998
17
Insulin resistance and arteriosclerosis obliterans in patients with NIDDM. (9353618)
1997
18
Hemodynamic changes in the lower limbs during treadmill walking in normal subjects and in patients with arteriosclerosis obliterans. (9313629)
1997
19
Comparison of arteriosclerosis obliterans of lower limbs between China and Japan. (2225282)
1990
20
beta-Pyridylcarbinol (Ronicol) releases a prostacyclin-like substance into arterial blood of patients with arteriosclerosis obliterans. (6346344)
1983
21
Prevalence of severe arteriosclerosis obliterans in patients with diabetes mellitus. Relation to smoking and form of therapy. (7052035)
1982
22
Lack of effect of ischemia and dipyridamole on prostacyclin production in arteriosclerosis obliterans. (7041195)
1981
23
Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. (86835)
1979
24
Serum lipids and lipoproteins in arteriosclerosis obliterans of the lower extremities. (750857)
1978
25
Factors influenced on prognosis of reconstructive surgery for peripheral arterial occlusion: comparative study between arteriosclerosis obliterans and thromboangiitis obliterans. (599159)
1977
26
Applications of ultrasound to the study of arteriosclerosis obliterans. (1090218)
1975
27
Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans). (4570447)
1973
28
Saphenous vein bypass grafts for arteriosclerosis obliterans in the femoropopliteal region. (4695292)
1973
29
Cigarette smoking and arteriosclerosis obliterans: an epidemiologic approach. (5007359)
1972
30
Lumbar sympathectomy for arteriosclerosis obliterans. (5419582)
1970
31
The natural course of peripheral arteriosclerosis obliterans evaluated by flow measurements. (5802451)
1969
32
A diagnostic aid for determining peripheral arteriosclerosis obliterans. (6058444)
1967
33
Pulse morphological plethysmography of the forefoot in arteriosclerosis obliterans. (6056910)
1967
34
Thromboangiitis obliterans and arteriosclerosis obliterans. (5833515)
1965
35
LUMBAR SYMPATHECTOMY IN ARTERIOSCLEROSIS OBLITERANS. (14179033)
1964
36
THROMBOANGIITIS OBLITERANS AND ARTERIOSCLEROSIS OBLITERANS. CLINICAL AND PROGNOSTIC DIFFERENCES. (14065946)
1963
37
A COMPARISON OF THE NATURAL HISTORY OF ARTERIOSCLEROSIS OBLITERANS WITH THE RESULTS OF ARTERIAL RECONSTRUCTION. (14053194)
1963
38
Severe ischemia of lower extremity due to arteriosclerosis obliterans. (13955713)
1963
39
Treatment of diabetic ulcer with concomitant arteriosclerosis obliterans. (14424139)
1960
40
Iliofemoropopliteal arterial reconstructions for arteriosclerosis obliterans; factors influencing late patency. (13622959)
1959
41
Arteriosclerosis obliterans of the lower extremity. (13620974)
1959
42
Oxygen utilization and lactic acid formation in the legs at rest and during exercise in normal subjects and in patients with arteriosclerosis obliterans. (13660772)
1959
43
Arteriosclerosis obliterans. (13640435)
1959
44
Muscle blood flow in patients with arteriosclerosis obliterans. (13559561)
1958
45
Coronary (ischaemic) heart disease in patients with arteriosclerosis obliterans. (13394194)
1956
46
An approach to the etiology, diagnosis and management of peripheral arteriosclerosis (arteriosclerosis obliterans). (13318639)
1956
47
Use of vasodilator drugs in the treatment of diabetic arteriosclerosis obliterans. (13162729)
1954
48
CLINICAL pathologic conference: diabetes mellitus with complications, including generalized arteriosclerosis, cerebral arteriosclerosis, coronary arteriosclerosis, hypertensive cardiovascular disease and arteriosclerosis obliterans of the extremities. (13011459)
1952
49
An evaluation of roniacol tartrate in arteriosclerosis obliterans. (14843421)
1951
50
Arteriosclerosis obliterans of the abdominal aorta. (20999992)
1946

Variations for Arteriosclerosis Obliterans

About this section

Expression for genes affiliated with Arteriosclerosis Obliterans

About this section
Search GEO for disease gene expression data for Arteriosclerosis Obliterans.

Pathways for genes affiliated with Arteriosclerosis Obliterans

About this section

Pathways related to Arteriosclerosis Obliterans according to GeneCards Suite gene sharing:

(show all 20)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.5ICAM1, SELP
29.5ICAM1, SELP
39.5SELP, ICAM1
49.4VCAM1, ICAM1
59.4VCAM1, ICAM1
69.4ICAM1, VCAM1
7
Show member pathways
RANKL/RANK Signaling Pathway36
Apoptosis and survival APRIL and BAFF signaling58
9.4ICAM1, VCAM1
89.4ICAM1, VCAM1
99.4VCAM1, ICAM1
10
Show member pathways
Development VEGF signaling via VEGFR2 generic cascades58
9.4ICAM1, VCAM1
119.4ICAM1, VCAM1
129.4ICAM1, VCAM1
139.4ICAM1, VCAM1
149.4VCAM1, ICAM1
159.4ICAM1, VCAM1
169.4ICAM1, VCAM1
17
Show member pathways
9.2HGF, SELP
189.0SELP, VCAM1, ICAM1
19
Show member pathways
8.6VCAM1, ICAM1, HGF
208.2HGF, ICAM1, VCAM1, SELP

Compounds for genes affiliated with Arteriosclerosis Obliterans

About this section

Compounds related to Arteriosclerosis Obliterans according to GeneCards Suite gene sharing:

(show top 50)    (show all 110)
idCompoundScoreTop Affiliating Genes
1thiolutin599.8SELP, ICAM1
2heparin sodium salt599.7SELP, ICAM1
3echistatin, alpha1 isoform599.7SELP, ICAM1
4rgds peptide599.7SELP, ICAM1
5sarpogrelate28 4310.7SELP, ADIPOQ
6ac2-26599.7ICAM1, SELP
7tetramethylpyrazine439.6SELP, ICAM1
8slea439.5ICAM1, SELP
9sele439.4ICAM1, VCAM1, SELP
10cuprophan439.4SELP, VCAM1, ICAM1
11slex439.4ICAM1, VCAM1, SELP
12budesonide43 49 1211.4SELP, ICAM1, VCAM1
13pentoxifylline43 1210.3ICAM1, SELP, VCAM1
14fluvastatin43 49 28 1212.3SELP, ICAM1, VCAM1
15mannitol43 1210.2SELP, ICAM1, VCAM1
16gliclazide43 49 1211.2VCAM1, ADIPOQ, ICAM1
17pdmp439.2ICAM1, SELP
188-isoprostane439.2VCAM1, ADIPOQ, ICAM1
19homocysteine43 2410.2ADIPOQ, SELP, VCAM1
20cilostazol43 1210.1HGF, VCAM1, SELP
21dextran sulfate439.0HGF, SELP, ICAM1
22cocaine43 1210.0VCAM1, ADIPOQ, SELP
23troglitazone43 28 59 1212.0ADIPOQ, ICAM1, VCAM1
24pdtc438.9ICAM1, VCAM1, HGF
25sp 60012543 599.9ICAM1, VCAM1, HGF
26carbohydrates438.9VCAM1, SELP, ADIPOQ
27fenofibrate43 49 1210.8ADIPOQ, VCAM1, ICAM1, SELP
28pravastatin43 49 28 24 1212.8SELP, ICAM1, VCAM1, ADIPOQ
29atorvastatin43 49 28 24 1212.8ADIPOQ, ICAM1, SELP, VCAM1
30simvastatin43 49 59 28 24 1213.8SELP, VCAM1, ADIPOQ, ICAM1
31rantes438.8SELP, VCAM1, ADIPOQ, ICAM1
32fibrinogen438.7SELP, VCAM1, ADIPOQ, ICAM1
33n acetylcysteine438.6HGF, ICAM1, SELP, VCAM1
34polysaccharide438.5ICAM1, VCAM1, HGF, SELP
35histamine43 28 2410.5VCAM1, SELP, ICAM1, HGF
36herbimycin a43 599.5ICAM1, HGF, VCAM1
37genistein43 28 59 2 24 1213.5VCAM1, ICAM1, HGF, SELP
38losartan43 49 28 1211.5HGF, ADIPOQ, VCAM1, SELP
39sodium nitroprusside438.5VCAM1, ADIPOQ, HGF, SELP
40norepinephrine43 24 1210.4HGF, VCAM1, SELP, ADIPOQ
41aspartate438.4HGF, SELP, VCAM1, ADIPOQ
42sb 20358043 599.4VCAM1, ICAM1, ADIPOQ, HGF
43heparin43 28 24 1211.4SELP, HGF, ADIPOQ, VCAM1
44adenylate438.4HGF, ADIPOQ, SELP, VCAM1
45prostacyclin438.0ADIPOQ, ICAM1, HGF, SELP, VCAM1
46ly294002438.0SELP, VCAM1, ADIPOQ, HGF, ICAM1
47pge2438.0VCAM1, ADIPOQ, ICAM1, HGF, SELP
48lactate438.0ADIPOQ, HGF, SELP, ICAM1, VCAM1
49dexamethasone43 49 28 1211.0SELP, VCAM1, ADIPOQ, ICAM1, HGF
50retinoic acid43 248.9HGF, SELP, ICAM1, ADIPOQ, VCAM1

GO Terms for genes affiliated with Arteriosclerosis Obliterans

About this section

Cellular components related to Arteriosclerosis Obliterans according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.0ICAM1, VCAM1, SELP
2extracellular spaceGO:00056157.2HGF, ICAM1, ADIPOQ, VCAM1, SELP

Biological processes related to Arteriosclerosis Obliterans according to GeneCards Suite gene sharing:

(show all 18)
idNameGO IDScoreTop Affiliating Genes
1leukocyte tethering or rollingGO:00509019.8VCAM1, SELP
2membrane to membrane dockingGO:00226149.7ICAM1, VCAM1
3cellular response to glucose stimulusGO:00713339.7ICAM1, VCAM1
4response to ionizing radiationGO:00102129.7ICAM1, VCAM1
5cellular response to tumor necrosis factorGO:00713569.6ICAM1, VCAM1
6interferon-gamma-mediated signaling pathwayGO:00603339.5VCAM1, ICAM1
7response to lipopolysaccharideGO:00324969.5VCAM1, SELP
8response to nutrientGO:00075849.4ADIPOQ, VCAM1
9positive regulation of phosphatidylinositol 3-kinase signalingGO:00140689.4SELP, HGF
10cell chemotaxisGO:00603269.3HGF, VCAM1
11regulation of immune responseGO:00507769.3VCAM1, ICAM1
12leukocyte cell-cell adhesionGO:00071599.3ICAM1, VCAM1, SELP
13heterophilic cell-cell adhesionGO:00071579.3SELP, VCAM1, ICAM1
14cell adhesionGO:00071559.2SELP, VCAM1, ICAM1
15platelet degranulationGO:00025769.2HGF, SELP
16leukocyte migrationGO:00509009.2ICAM1, SELP
17response to ethanolGO:00454719.1VCAM1, ADIPOQ, ICAM1
18positive regulation of peptidyl-tyrosine phosphorylationGO:00507318.8HGF, ICAM1, ADIPOQ

Molecular functions related to Arteriosclerosis Obliterans according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1integrin bindingGO:00051789.4ICAM1, VCAM1
2sialic acid bindingGO:00336919.1ADIPOQ, SELP

Products for genes affiliated with Arteriosclerosis Obliterans

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Arteriosclerosis Obliterans

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet